Slovenia vs Estonia vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 95% | 83% |
| 2023 | 95% | 85% |
| 2022 | 96% | 87% |
| 2021 | 95% | 89% |
| 2020 | 94% | 91% |
| 2019 | 94% | 88% |
| 2018 | 93% | 87% |
| 2017 | 93% | 93% |
| 2016 | 92% | 93% |
| 2015 | 94% | 93% |
| 2014 | 94% | 93% |
| 2013 | 94% | 94% |
| 2012 | 95% | 94% |
| 2011 | 96% | 94% |
| 2010 | 95% | 95% |
| 2009 | 95% | 95% |
| 2008 | 96% | 95% |
| 2007 | 96% | 96% |
| 2006 | 96% | 96% |
| 2005 | 94% | 96% |
| 2004 | 94% | 96% |
| 2003 | 94% | 95% |
| 2002 | 93% | 95% |
| 2001 | 94% | 95% |
| 2000 | 95% | 93% |
| 1999 | 98% | 92% |
| 1998 | 93% | 89% |
| 1997 | 82% | 88% |
| 1996 | 93% | 86% |
| 1995 | 93% | 81% |
| 1994 | 91% | 76% |
| 1993 | 90% | 74% |
| 1992 | 90% | - |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 90% | 81% |
| 2023 | 89% | 84% |
| 2022 | 89% | 87% |
| 2021 | 86% | 90% |
| 2020 | 95% | 91% |
| 2019 | 95% | 91% |
| 2018 | 93% | 92% |
| 2017 | 94% | 93% |
| 2016 | 94% | 93% |
| 2015 | 95% | 93% |
| 2014 | 95% | 93% |
| 2013 | 95% | 94% |
| 2012 | 96% | 94% |
| 2011 | 96% | 93% |
| 2010 | 96% | 94% |
| 2009 | 96% | 95% |
| 2008 | 97% | 95% |
| 2007 | 97% | 95% |
| 2006 | 97% | 95% |
| 2005 | 95% | 96% |
| 2004 | 94% | 94% |
| 2003 | 95% | 94% |
| 2002 | 93% | 94% |
| 2001 | 92% | 94% |
| 2000 | 91% | 93% |
| 1999 | 92% | 91% |
| 1998 | 91% | 88% |
| 1997 | 94% | 87% |
| 1996 | 98% | 87% |
| 1995 | 98% | 82% |
| 1994 | 98% | 77% |
| 1993 | 98% | 71% |
| 1992 | 98% | - |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 90% | 81% |
| 2023 | 89% | 82% |
| 2022 | 89% | 83% |
| 2021 | 86% | 84% |
| 2020 | - | 90% |
| 2019 | - | 91% |
| 2018 | - | 93% |
| 2017 | - | 92% |
| 2016 | - | 93% |
| 2015 | - | 91% |
| 2014 | - | 93% |
| 2013 | - | 93% |
| 2012 | - | 94% |
| 2011 | - | 94% |
| 2010 | - | 94% |
| 2009 | - | 95% |
| 2008 | - | 94% |
| 2007 | - | 95% |
| 2006 | - | 95% |
| 2005 | - | 95% |
| 2004 | - | 90% |
| 2003 | - | - |
| 2002 | - | - |
| 2001 | - | - |
| 2000 | - | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 95% of children aged 12–23 months in Slovenia and 83% in Estonia: 12 percentage points more in Slovenia. The third DTP dose reaches 90% in Slovenia and 81% in Estonia, 9 points more in Slovenia. The third hepatitis B dose reaches 90% in Slovenia and 81% in Estonia, 9 points more in Slovenia. In 1993, the first measles dose reached 90% in Slovenia and 74% in Estonia, 16 percentage points more in Slovenia.
Slovenia vs Estonia: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 95% (2024) | 83% (2024) |
| DTP3 | 90% (2024) | 81% (2024) |
| HepB3 | 90% (2024) | 81% (2024) |
Slovenia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Estonia and nearby countries: measles vaccination (MCV1), % of children aged 12–23 months
Of Slovenia and its four neighbors, the latest coverage of the first measles dose is highest in Hungary, at 99%, and lowest in Austria, at 90%; of Estonia and the five nearby countries, the latest coverage of the first measles dose is highest in Latvia, at 98%, and lowest in Estonia, at 83%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.